Feed Insights Top Reports Pricing

⌘K

16:17:05·1719d

SECFilingvia Quantisnow

SEC Form 10-Q filed by AXT Inc

ByQuantisnow·Wall Street's wire, on your screen.

Technology

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AXTI (AXT Inc) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

AXTI
AXT Inc
Technology

Recent analyst ratings

Jan 20UpdateNeedham-
Jan 9UpdateB. Riley Securities$18.00
Feb 23UpdateCraig Hallum$3.75
Feb 23UpdateB. Riley Securities$3.80
Feb 17UpdateCraig Hallum$5.50
Jun 27UpdateNeedham$8.00

Related

PR3d
AXT Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
PR3d
Tradr Launches Leveraged ETFs on AXTI, CPNG, MPWR and STX
PR4d
Tradr Set to Launch Leveraged ETFs on AXTI, CPNG, MPWR and STX
PR5d
AXT Announces Closing of Public Offering of Common Stock
SEC6d
SEC Form 424B5 filed by AXT Inc
SEC6d
AXT Inc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
PR6d
AXT Announces Pricing of $550 Million Public Offering of Common Stock
SEC7d
AXT Inc filed SEC Form 8-K: Results of Operations and Financial Condition

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022